Cleared Traditional

K212113 - MagXtract Collection Tube (FDA 510(k) Clearance)

Class II Microbiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K212113 · Magbio Genomics, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
386d
Days
Class 2
Risk

K212113 is an FDA 510(k) clearance for the MagXtract Collection Tube. Classified as Microbial Nucleic Acid Storage And Stabilization Device (product code QBD), Class II - Special Controls.

Submitted by Magbio Genomics, Inc. (Gaithersburg, US). The FDA issued a Cleared decision on July 28, 2022 after a review of 386 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2950 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Magbio Genomics, Inc. devices

Submission Details

510(k) Number K212113 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2021
Decision Date July 28, 2022
Days to Decision 386 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
284d slower than avg
Panel avg: 102d · This submission: 386d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QBD Microbial Nucleic Acid Storage And Stabilization Device
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.2950
Definition Molecular Transport Media Is A Device Intended For The Stabilization And Transportation Of Nucleic Acids From Unprocessed Human Samples Suspected Of Containing Infectious Material.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Consultant

Brij Strategic Consultations, LLC
Mukesh Kumar

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QBD Microbial Nucleic Acid Storage And Stabilization Device

All 16
Devices cleared under the same product code (QBD) and FDA review panel - the closest regulatory comparables to K212113.
Puritan PurSafe Plus Collection and Transport System
K242820 · Puritan Medical Products, LLC · May 2025
PPH Saliva Collection Kit
K240797 · Permantis Public Health · Oct 2024
Sample Preservative Fluid
K222771 · Hangzhou Bioer Technology Co., Ltd. · Jun 2024
Molecular Transport Media - MTM
K233324 · Alb Luz · Jun 2024
InActiv Blue
K221547 · Fertipro NV · Jun 2024
Sample preservation solution
K212878 · Zhejiang Gene Science Co., Ltd. · Apr 2024